Trademark: 77504998
Word
NASALCARE
Status
Registered
Status Code
800
Status Date
Tuesday, January 7, 2020
Serial Number
77504998
Registration Number
3688173
Registration Date
Tuesday, September 29, 2009
Mark Type
3000
Filing Date
Sunday, June 22, 2008
Published for Opposition
Tuesday, January 20, 2009

Trademark Owner History
TechWorld Corporation, Inc. - Original Registrant

Classifications
5 [ Analgesic and muscle relaxant pharmaceutical preparations; Anti-diabetic pharmaceuticals; ] Antibacterial pharmaceuticals; [ Antimicrobial preparations for inhibiting microbiological decomposition in food, beverages, animal feed and pharmaceuticals; ] [ Antimicrobial preservatives for cosmetics and pharmaceuticals; ] [ Astringents; Bismuth preparations for pharmaceutical purposes; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; ] Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; [ Drug delivery agents in the form of a coating for macromolecule agents that facilitate the delivery of a wide range of pharmaceuticals; Gelatin capsules sold empty for pharmaceuticals; ] Homeopathic pharmaceuticals for use in the treatment of allergy and respiratory tract infections; [ Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Inhalers filled with anti-infectives and anti-allergy pharmaceuticals; ] [ Injectable pharmaceuticals for treatment of anaphylactic reactions; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Ocular pharmaceuticals; Pharmaceutical anti-allergic preparations and substances; ] Pharmaceutical antitussive-cold preparations; [ Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; ] Pharmaceutical preparations and substances for the treatment of infectious diseases, [ blood disorders, ] pain, inflammation [, sepsis, alopecia, obesity and cognitive disorders ] ; [ Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; ] Pharmaceutical preparations for the prevention and treatment of [ ocular disorders or diseases, for the treatment of ] bacteria-based diseases, [ and for the treatment of diabetes, ] and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations [ and vaccines ] ; [ Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; ] Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; [ Pharmaceutical preparations for treating diabetes; ] Pharmaceutical preparations for use in chemotherapy; [ Pharmaceutical preparations for use in urology; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of joint disease; ] Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; [ Pharmaceutical solutions used in dialysis; Pharmaceuticals for the treatment of erectile dysfunction; ] Pharmaceuticals, namely, anti-infectives; [ Pharmaceuticals, namely, antihelmintics; ] [ Pharmaceuticals, namely, inducers of erections; Pharmaceuticals, namely, lipid lowering agents; Plant extracts for medical, veterinary and pharmaceutical purposes; ] [ Potassium preparations for pharmaceutical purposes; ] [ Radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use; Synthetic peptides for pharmaceutical purposes; Unit dose capsules sold empty for pharmaceutical use; Vitamin and mineral preparations for use as ingredients in the food and pharmaceutical industry; Yeast or yeast extracts for medical, veterinary or pharmaceutical purposes ]
Color is not claimed as a feature of the mark.
"NASALCARE"
The mark consists of the wording "NASALCARE" with two curved lines representing air or vapor emanating from the "L".
NASAL CARE

Trademark Events
Jan 7, 2020
Notice Of Acceptance Of Sec. 8 & 9 - E-Mailed
Jan 7, 2020
Registered And Renewed (First Renewal - 10 Yrs)
Jan 7, 2020
Registered - Sec. 8 (10-Yr) Accepted/Sec. 9 Granted
Jan 6, 2020
Teas Response To Office Action-Post Reg Received
Jan 3, 2020
Teas Change Of Correspondence Received
Jul 7, 2019
Post Registration Action Mailed - Sec. 8 & 9
Jul 7, 2019
Case Assigned To Post Registration Paralegal
Jun 21, 2019
Teas Change Of Correspondence Received
Jun 21, 2019
Teas Section 8 & 9 Received
Sep 29, 2018
Courtesy Reminder - Sec. 8 (10-Yr)/Sec. 9 E-Mailed
Oct 12, 2016
Notice Of Acceptance Of Sec. 8 & 15 - E-Mailed
Oct 12, 2016
Registered - Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Sep 28, 2016
Teas Response To Office Action-Post Reg Received
Sep 27, 2016
Teas Response To Office Action-Post Reg Received
Jun 6, 2016
Teas Change Of Correspondence Received
May 27, 2016
Teas Change Of Correspondence Received
Apr 8, 2016
Teas Change Of Correspondence Received
Apr 3, 2016
Teas Change Of Correspondence Received
Mar 28, 2016
Post Registration Action Mailed - Sec. 8 & 15
Mar 25, 2016
Teas Change Of Correspondence Received
Mar 25, 2016
Teas Section 8 & 15 Received
Dec 13, 2014
Post Registration Action Mailed - Sec. 8 & 15
Nov 24, 2014
Teas Response To Office Action-Post Reg Received
Oct 6, 2014
Post Registration Action Mailed - Sec. 8 & 15
Oct 6, 2014
Case Assigned To Post Registration Paralegal
Sep 30, 2014
Teas Section 8 & 15 Received
Sep 30, 2014
Teas Change Of Correspondence Received
Sep 29, 2009
Registered-Principal Register
Aug 26, 2009
Ttab Release Case To Trademarks
Aug 26, 2009
Opposition Terminated No. 999999
Aug 26, 2009
Opposition Dismissed No. 999999
Mar 12, 2009
Opposition Instituted No. 999999
Feb 4, 2009
Extension Of Time To Oppose Received
Jan 20, 2009
Published For Opposition
Dec 31, 2008
Notice Of Publication
Dec 16, 2008
Law Office Publication Review Completed
Dec 16, 2008
Approved For Pub - Principal Register
Dec 16, 2008
Teas/Email Correspondence Entered
Dec 16, 2008
Correspondence Received In Law Office
Dec 16, 2008
Assigned To Lie
Dec 1, 2008
Teas Change Of Correspondence Received
Dec 1, 2008
Teas Response To Office Action Received
Oct 3, 2008
Notification Of Non-Final Action E-Mailed
Oct 3, 2008
Non-Final Action E-Mailed
Oct 3, 2008
Non-Final Action Written
Sep 26, 2008
Assigned To Examiner
Jun 26, 2008
Notice Of Design Search Code Mailed
Jun 25, 2008
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24